Notably, B7-H6M4-LC21 combined with IL-15 fusion protein elicited synergistic tumor lysis (>90% at 10 ng/mL in vitro) and enhanced in vivo antitumor efficacy, surpassing T cell-based modalities. The gene discussed is IL15; the disease is neoplasm.